Pages that link to "Q71579962"
Jump to navigation
Jump to search
The following pages link to Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) (Q71579962):
Displaying 24 items.
- Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines (Q28553697) (← links)
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia (Q33733461) (← links)
- Hematopoietic stem cell transplantation for leukemia (Q34034180) (← links)
- Lymphoblastic lymphoma (Q34186596) (← links)
- Early Response to Dexamethasone as Prognostic Factor: Result from Indonesian Childhood WK-ALL Protocol in Yogyakarta (Q34252624) (← links)
- Risk assessment in ALL in children: a focus on PCR-based techniques for MRD detection (Q34296765) (← links)
- SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution (Q34989431) (← links)
- Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia (Q35046100) (← links)
- Flow Cytometric Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia (Q35562484) (← links)
- Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. (Q35831218) (← links)
- Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China (Q35853569) (← links)
- Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia (Q36094717) (← links)
- Use of Recombinant Cell-Permeable Small Peptides To Modulate Glucocorticoid Sensitivity of Acute Lymphoblastic Leukemia Cells (Q39657220) (← links)
- Early response to therapy and outcome in childhood acute lymphoblastic leukemia (Q41627640) (← links)
- Biologic Prognostic Factors in Acute Lymphoblastic Leukemia (Q41650675) (← links)
- Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia (Q43120483) (← links)
- The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia (Q44398741) (← links)
- Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group (Q47771698) (← links)
- Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome (Q51631789) (← links)
- Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. (Q52966697) (← links)
- JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia. (Q55516451) (← links)
- Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia (Q59094263) (← links)
- Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report (Q73555742) (← links)
- Acute lymphoblastic leukemia (Q73671864) (← links)